Gerald Torgesen, DPM
Foot & Ankle Surgery · Henderson, NVNPI 1942292883
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,824 of the $7,685 with a category attached, or 75.8%. It is spread thinly across 42 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,745 and has fallen 86.1% since, to $382 in 2025.
Across 236 payments — averaging $32.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Goode Surgical Inc$2K
- Treace Medical Concepts, Inc.$1K
- Organogenesis Inc.$612
- Stryker$409
- Amgen$403
- Paratek Pharmaceuticals, Inc.$349
- plus $3K from 36 others
What the payments were for
- Food & beverage$5,82476%
- Education$1,76523%
- Gifts$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$392
- Subchondroplasty$165
- Rotarex$128
- Iovera$120
- Lapiplasty System$107
How this compares
$7,685 in reported general payments places this provider in the 70th percentile of 84 foot & ankle surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 66 | $669 |
| Diclofenac Sodium | 22 | $502 |
| Celecoxib | 38 | $476 |
| Meloxicam | 197 | $404 |
| Allopurinol | 31 | $291 |
| Ciclopirox | 12 | $289 |
| Terbinafine Hcl | 12 | $161 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $88 |
| Cephalexin | 17 | $72 |
| Cefadroxil | 18 | $67 |
| Methylprednisolone | 14 | $65 |
| Triamcinolone Acetonide | 16 | $64 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Henderson
- Roman SibelHenderson$309K
- Holman ChanHenderson$75K
- Jeremy TiltonHenderson$51K
- Richard GardnerHenderson$9K
- Troy McArthurHenderson$5K
- Philip LarsenHenderson$4K
- Roger ReedHenderson$3K
- Michael KooymanHenderson$2K
- Douglas StaceyHenderson$2K
- Joshua LisonbeeHenderson$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.